Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrent Platinum Resistant Ovarian Cancer 1Rectal Neoplasms 1Neoplasm Metastasis 1Colorectal Neoplasms 1Carcinoma 1Adenoviridae Infections 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × enadenotucirev × Clear all
NCT03916510 2025-02-06

CEDAR

University of Oxford

Phase 1 Completed
12 enrolled 13 charts
Gastrointestinal

Adenoviridae Infections, Rectal Neoplasms

NCT02636036 2021-11-09

SPICE

Akamis Bio

Phase 1 Completed
51 enrolled
GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT02028117 2021-05-13

OCTAVE

Akamis Bio

Phase 1 Completed
38 enrolled
Gynecologic

Recurrent Platinum Resistant Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡